This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
MorphoSys is dealing with an emerging safety issue related to pelabresib, the experimental treatment for myelofibrosis and centerpiece of its proposed $3 billion acquisition by Novartis, STAT has learned. Physicians involved with MorphoSys’ completed Phase 3 study have reported multiple cases of palebresib-treated patients who rapidly progressed from myelofibrosis, a cancer affecting the bone marrow, to acute myeloid leukemia, a more aggressive and deadlier type of blood cancer, according
Artificial intelligence tools can be used for infection control through facial recognition systems designed to identify proper face mask use within hospitals.
As countries resume final negotiations on Monday for a landmark pandemic agreement intended to help prevent and rapidly respond to the next inevitable pandemic, I’m getting a sense of déjà vu. Why? The draft text has watered down intellectual property (IP) obligations in an attempt to achieve compromise on this issue. Diluting international obligations to achieve consensus is reminiscent of the limited waiver of one international patent obligation for Covid vaccines after two ye
Exclusive: ‘Distressing’ scarcity sowing uncertainty among 400,000 with type 1 diabetes, experts warn People with type 1 diabetes are being forced to endure the “stress and anxiety” of insulin shortages, patients, pharmacists and health campaigners have warned. The “distressing” drug scarcity, the latest to affect the UK, is sowing uncertainty for the 400,000 people with the condition, with some products not available again until next year amid global manufacturing shortages.
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Pfizer has said it will launch its just-approved haemophilia B gene therapy Beqvez with a warranty programme that will provide “greater certainty” to payers, after setting a price directly in line with a rival treatment.
Report from Evaluate shows growth in the orphan drugs sector is slowing down, in part as pharma and payers’ attention has refocused on treatments for more widespread conditions like obesity
110
110
Signup to get articles personalized to your interests!
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Report from Evaluate shows growth in the orphan drugs sector is slowing down, in part as pharma and payers’ attention has refocused on treatments for more widespread conditions like obesity
In this episode, I’ll discuss the impact of achieving an aggressive PK/PD target for beta lactams in critically ill patients. Episode 917: What is the impact of achieving an aggressive PK/PD target for beta lactams in critically ill patients? Subscribe on iTunes , Android , or Stitcher Therapeutic drug monitoring for beta-lactams has not yet made it to the mainstream in all hospitals, but data continues to accumulate that I believe will eventually compel clinicians to check blood levels of
Introduction Structured Query Language (SQL) empowers data analysts to communicate with their databases. While spreadsheets (e.g. Microsoft Excel and Google Sheets) offer data storage and management, databases excel at handling larger and more complex datasets. Popular SQL programs include MySQL , Microsoft SQL Server and BigQuery. SQL Statements Database actions are primarily performed using SQL statements, which consist of easy-to-understand keywords like: Database CREATE DATABASE - Creates a
Meningococcal Disease Background Meningococcal disease is a severe, life-threatening illness that may manifest as meningitis, bacteremia, or bacteremic pneumonia. Even with antibiotic treatment, mortality due to invasive disease is 10-15%. Up to 20% of persons who become ill with invasive meningococcal disease may experience life-long disabilities, such as loss of limbs, deafness, cognitive deficits, and […] The post Meningococcal Prophylaxis – CDC Recommendations and Updates appeare
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Introduction In today's digital world, we constantly generate information, from swiping credit cards to browsing the web. This abundance necessitates the ability to analyze and interpret it into actionable insights. Data: The Foundation “Data! Data! Data! I can't make bricks without clay!"—— Sherlock Holmes via Sir Arthur Conan Doyle Now, data science, the discipline of making data useful, is an umbrella term that encompasses 3 disciplines.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content